[Federal Register Volume 66, Number 155 (Friday, August 10, 2001)]
[Notices]
[Page 42240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-20107]



[[Page 42240]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 16, 2001, Roche 
Diagnostics Corporation, 9115 Hague Road, Indianapolis, Indiana 46250, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
Phencyclidine (7471).......................  II
Benzoylecgonine (9180).....................  II
methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substances for incorporation in drug of 
abuse detection kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 9, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-20107 Filed 8-9-01; 8:45 am]
BILLING CODE 4410-09-M